Active, not recruitingNot applicableNCT03357445
AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study
Studying Idiopathic avascular necrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zimmer Biomet
- Principal Investigator
- Hassan AchakriZimmer Biomet
- Intervention
- Avantage Reload cup(other)
- Enrollment
- 500 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2027
Study locations (4)
- CHU Cote de Nacre, Caen, France
- Hôpital Renée Sabran, Giens, France
- CHU Lapeyronie, Montpellier, France
- Hospital Novo Mesto, Novo Mesto, Slovenia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03357445 on ClinicalTrials.govOther trials for Idiopathic avascular necrosis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT07471880A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral HeadZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
- ACTIVE NOT RECRUITINGNANCT01458782ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the KneeUniversity Hospital of North Norway
- RECRUITINGNCT05603728Exactech Shoulder Post Market Clinical Follow-up StudyExactech